Rockland boosts life sciences portfolio with purchase of antibody line

21st Century Biochemicals agreed to sell its line of Epi-Plus antibodies, which are used in epigenetic studies, to Rockland Immunochemicals. The price was not disclosed. The deal will bolster Rockland's life science tools portfolio. The Epi-Plus brand is co-owned by Novus Biologicals.

View Full Article in:

Genetic Engineering & Biotechnology News · GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN